Thulium fiber laser enucleation of the prostate: a systematic review of the current outcomes.


Journal

Minerva urology and nephrology
ISSN: 2724-6442
Titre abrégé: Minerva Urol Nephrol
Pays: Italy
ID NLM: 101777299

Informations de publication

Date de publication:
Apr 2024
Historique:
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 14 5 2024
Statut: ppublish

Résumé

One recent addition to different lasers used for endoscopic enucleation of the prostate is the thulium fiber laser (TFL). The purpose of this systematic review is to present the feasibility, safety and efficacy of TFL Enucleation of the Prostate (ThuFLEP). PubMed Twelve studies met all the predefined criteria and were included in the final qualitative synthesis. Mean operative time and enucleation time ranged from 46.6±10.2 to 104.5±33.6 and from 38.8±17.9 to 66.0±24.9 minutes, respectively. Most of the complications were Grade I or Grade II ones. Although TFL was found to present some advantages over older BPO treatments, its outcomes were comparable with other endoscopic enucleation approaches. ThuFLEP seems to be a feasible, safe and efficient approach for BPO symptoms management. Limited evidence showed that although ThuFLEP was associated with a reduced total operative time, it was also associated with worse IPSS improvement at 1-year follow-up, when compared with MOSES

Identifiants

pubmed: 38742551
pii: S2724-6051.24.05654-4
doi: 10.23736/S2724-6051.24.05654-4
doi:

Types de publication

Journal Article Systematic Review Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

157-165

Auteurs

Theodoros Spinos (T)

Department of Urology, University Hospital of Patras, Patras, Greece.

Vasileios Tatanis (V)

Department of Urology, University Hospital of Patras, Patras, Greece.

Angelis Peteinaris (A)

Department of Urology, University Hospital of Patras, Patras, Greece.

Bhaskar Somani (B)

Department of Urology, University Hospital of Southampton, Southampton, UK.

Ioannis Kartalas Goumas (I)

Department of Urology, Beato Matteo Clinical Institute, Vigevano, Pavia, Italy.

Evangelos Liatsikos (E)

Department of Urology, University Hospital of Patras, Patras, Greece.
Department of Urology, Medical University of Vienna, Vienna, Austria.

Panagiotis Kallidonis (P)

Department of Urology, University Hospital of Patras, Patras, Greece - pkallidonis@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH